Authors:
Boyle, P
Robertson, C
Manski, R
Padley, RJ
Roehrborn, CG
Citation: P. Boyle et al., Meta-analysis of randomized trials of terazosin in the treatment of benignprostatic hyperplasia, UROLOGY, 58(5), 2001, pp. 717-722
Authors:
Honing, MLH
Hijmering, ML
Ballard, DE
Yang, YHP
Padley, RJ
Morrison, PJ
Rabelink, TJ
Citation: Mlh. Honing et al., Selective ETA receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans, J AM S NEPH, 11(8), 2000, pp. 1498-1504
Authors:
Verhaar, MC
Grahn, AY
van Weerdt, AWM
Honing, MLH
Morrison, PJ
Yang, YHP
Padley, RJ
Rabelink, TJ
Citation: Mc. Verhaar et al., Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans, BR J CL PH, 49(6), 2000, pp. 562-573
Authors:
Opgenorth, TJ
Wessale, JL
Dixon, DB
Adler, AL
Calzadilla, SV
Padley, RJ
Wu-Wong, JR
Citation: Tj. Opgenorth et al., Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level, J CARDIO PH, 36, 2000, pp. S292-S296
Authors:
Burke, SE
Nelson, RA
Lubbers, NL
Ford, TT
Fu, KI
Padley, RJ
Wegner, CD
Cox, BF
Citation: Se. Burke et al., Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine, J CARDIO PH, 35(6), 2000, pp. 838-844
Citation: Mf. Jarvis et al., ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain, EUR J PHARM, 388(1), 2000, pp. 29-35
Citation: Fc. Lowe et al., Effects of terazosin therapy on blood pressure in men with benign prostatic hyperplasia concurrently treated with other antihypertensive medications, UROLOGY, 54(1), 1999, pp. 81-85